Australija - engleski - Department of Health (Therapeutic Goods Administration)

helix pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; sodium citrate dihydrate; colloidal anhydrous silica; crospovidone; microcrystalline cellulose - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

helix pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium citrate dihydrate; povidone; crospovidone - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

waymade australia pty limited - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sunset yellow fcf aluminium lake; magnesium stearate; colloidal anhydrous silica; quinoline yellow aluminium lake; purified talc; pregelatinised starch - thyrox is indicated for the management of demonstrated thyroid hormone deficiency.,thyrox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

waymade australia pty limited - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; allura red ac aluminium lake; magnesium stearate; colloidal anhydrous silica; purified talc - thyrox is indicated for the management of demonstrated thyroid hormone deficiency.,thyrox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

waymade australia pty limited - levothyroxine sodium, quantity: 0.025 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sunset yellow fcf aluminium lake; magnesium stearate; colloidal anhydrous silica; purified talc; pregelatinised starch - thyrox is indicated for the management of demonstrated thyroid hormone deficiency.,thyrox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

waymade australia pty limited - levothyroxine sodium, quantity: 0.05 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; purified talc; pregelatinised starch - thyrox is indicated for the management of demonstrated thyroid hormone deficiency.,thyrox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

waymade australia pty limited - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; allura red ac aluminium lake; magnesium stearate; colloidal anhydrous silica; indigo carmine aluminium lake; purified talc; pregelatinised starch - thyrox is indicated for the management of demonstrated thyroid hormone deficiency.,thyrox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Irska - engleski - HPRA (Health Products Regulatory Authority)

mcdowell pharmaceuticals - colestyramine - powder for oral suspension - 4 grams

Irska - engleski - HPRA (Health Products Regulatory Authority)

bristol-myers squibb (holdings) limited - colestyramine -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.1387 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; lactose; croscarmellose sodium; purified water; gelatin; aluminium starch octenylsuccinate; aluminium sodium silicate; sucrose; medium chain triglycerides - the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.